BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33850302)

  • 1. Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma.
    Penning AJ; Al-Ibraheemi A; Michal M; Larsen BT; Cho SJ; Lockwood CM; Paulson VA; Liu YJ; Plank L; Fritchie K; Beadling C; Neff TL; Corless CL; Rudzinski ER; Davis JL
    Mod Pathol; 2021 Aug; 34(8):1530-1540. PubMed ID: 33850302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma.
    Kao YC; Fletcher CDM; Alaggio R; Wexler L; Zhang L; Sung YS; Orhan D; Chang WC; Swanson D; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2018 Jan; 42(1):28-38. PubMed ID: 28877062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALK rearrangements in infantile fibrosarcoma-like spindle cell tumours of soft tissue and kidney.
    Tan SY; Al-Ibraheemi A; Ahrens WA; Oesterheld JE; Fanburg-Smith JC; Liu YJ; Spunt SL; Rudzinski ER; Coffin C; Davis JL
    Histopathology; 2022 Mar; 80(4):698-707. PubMed ID: 34843129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinase fusion positive intra-osseous spindle cell tumors: A series of eight cases with review of the literature.
    Suurmeijer AJH; Xu B; Torrence D; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23205. PubMed ID: 37782551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes.
    Suurmeijer AJH; Dickson BC; Swanson D; Zhang L; Sung YS; Cotzia P; Fletcher CDM; Antonescu CR
    Genes Chromosomes Cancer; 2018 Dec; 57(12):611-621. PubMed ID: 30276917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second Report of
    Hughes CE; Correa H; Benedetti DJ; Smith B; Sumegi J; Bridge J
    Pediatr Dev Pathol; 2021; 24(6):554-558. PubMed ID: 34120511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent CD30 Expression in an Emerging Group of Mesenchymal Tumors With NTRK, BRAF, RAF1, or RET Fusions.
    Kojima N; Mori T; Motoi T; Kobayashi E; Yoshida M; Yatabe Y; Ichikawa H; Kawai A; Yonemori K; Antonescu CR; Yoshida A
    Mod Pathol; 2023 Apr; 36(4):100083. PubMed ID: 36788089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma-like mesenchymal tumors.
    Motta M; Barresi S; Pizzi S; Bifano D; Lopez Marti J; Garrido-Pontnou M; Flex E; Bruselles A; Giovannoni I; Rotundo G; Fragale A; Tirelli V; Vallese S; Ciolfi A; Bisogno G; Alaggio R; Tartaglia M
    J Pathol; 2024 Jun; 263(2):166-177. PubMed ID: 38629245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital mesoblastic nephroma is characterised by kinase mutations including EGFR internal tandem duplications, the ETV6-NTRK3 fusion, and the rare KLHL7-BRAF fusion.
    Zhao M; Yin M; Kuick CH; Chen H; Aw SJ; Merchant K; Ng EHQ; Gunaratne S; Loh AHP; Gu W; Tang H; Chang KTE
    Histopathology; 2020 Oct; 77(4):611-621. PubMed ID: 32590884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors.
    Kang J; Park JW; Won JK; Bae JM; Koh J; Yim J; Yun H; Kim SK; Choi JY; Kang HJ; Kim WS; Shin JH; Park SH
    Diagn Pathol; 2020 Sep; 15(1):114. PubMed ID: 32957984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spindle cell sarcoma with
    Fujikawa T; Uemura S; Yoshida M; Hyodo S; Kozaki A; Saito A; Kishimoto K; Ishida T; Mori T; Uematsu A; Morita K; Hatakeyama T; Tamura A; Yamamoto N; Komatsu M; Soejima T; Hasegawa D; Kosaka Y
    Oncol Lett; 2022 Dec; 24(6):452. PubMed ID: 36380878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent RET gene fusions in paediatric spindle mesenchymal neoplasms.
    Davis JL; Vargas SO; Rudzinski ER; López Marti JM; Janeway K; Forrest S; Winsnes K; Pinto N; Yang SE; VanSandt M; Boyd TK; Corless CL; Liu YJ; Surrey LF; Harris MH; Church A; Al-Ibraheemi A
    Histopathology; 2020 Jun; 76(7):1032-1041. PubMed ID: 31994201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive clinicopathological, molecular, and methylation analysis of mesenchymal tumors with NTRK and other kinase gene aberrations.
    Klubíčková N; Dermawan JK; Mosaieby E; Martínek P; Vaněček T; Hájková V; Ptáková N; Grossmann P; Šteiner P; Švajdler M; Kinkor Z; Michalová K; Szepe P; Plank L; Hederová S; Kolenová A; Spasov NJ; Kosemehmetoglu K; Pažanin L; Špůrková Z; Baník M; Baumruk L; Meyer A; Kalmykova A; Koshyk O; Michal M; Michal M
    J Pathol; 2024 May; 263(1):61-73. PubMed ID: 38332737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.
    Church AJ; Calicchio ML; Nardi V; Skalova A; Pinto A; Dillon DA; Gomez-Fernandez CR; Manoj N; Haimes JD; Stahl JA; Dela Cruz FS; Tannenbaum-Dvir S; Glade-Bender JL; Kung AL; DuBois SG; Kozakewich HP; Janeway KA; Perez-Atayde AR; Harris MH
    Mod Pathol; 2018 Mar; 31(3):463-473. PubMed ID: 29099503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusions.
    Massoth LR; Hung YP; Nardi V; Nielsen GP; Hasserjian RP; Louissaint A; Fisch AS; Deshpande V; Zukerberg LR; Lennerz JK; Selig M; Glomski K; Patel PJ; Williams KJ; Sokol ES; Alexander BM; Vergilio JA; Ross JS; Pavlick DC; Chebib I; Williams EA
    Mod Pathol; 2020 Nov; 33(11):2307-2317. PubMed ID: 32461620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and Neck Mesenchymal Tumors with Kinase Fusions: A Report of 15 Cases With Emphasis on Wide Anatomic Distribution and Diverse Histologic Appearance.
    Xu B; Suurmeijer AJH; Agaram NP; Antonescu CR
    Am J Surg Pathol; 2023 Feb; 47(2):248-258. PubMed ID: 36638315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors.
    Bourgeois JM; Knezevich SR; Mathers JA; Sorensen PH
    Am J Surg Pathol; 2000 Jul; 24(7):937-46. PubMed ID: 10895816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibrosarcoma Revisited: An Institutional Case Series of Uterine Sarcomas Harboring Kinase-related Fusions With Report of a Novel FGFR1-TACC1 Fusion.
    Devereaux KA; Weiel JJ; Mills AM; Kunder CA; Longacre TA
    Am J Surg Pathol; 2021 May; 45(5):638-652. PubMed ID: 33481389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of oncogenic fusions in mismatch repair deficient colorectal carcinomas by sequential DNA and RNA next generation sequencing.
    Wang J; Li R; Li J; Yi Y; Liu X; Chen J; Zhang H; Lu J; Li C; Wu H; Liang Z
    J Transl Med; 2021 Oct; 19(1):433. PubMed ID: 34657620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spindle Cell Tumors With RET Gene Fusions Exhibit a Morphologic Spectrum Akin to Tumors With NTRK Gene Fusions.
    Antonescu CR; Dickson BC; Swanson D; Zhang L; Sung YS; Kao YC; Chang WC; Ran L; Pappo A; Bahrami A; Chi P; Fletcher CD
    Am J Surg Pathol; 2019 Oct; 43(10):1384-1391. PubMed ID: 31219820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.